Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Zanubrutinib Combined with R-CHOP As the First-Line Treatment for Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Prospective Phase II Trial in China

Chongling Hu, Tao Yang, Li Jun, Wenjun Zhang, Bingling Guo, Chaoyu Wang, Jun Liu, Chunyan Xiao, Dehong Huang, Zailin Yang, Tingting Liu, Jieping Li, Yingyu Nan, Yao Liu

Blood (2023) 142 (Supplement 1): 6285.

https://doi.org/10.1182/blood-2023-188060

Published: 2023

Journal Articles

Risk Factors of Venous Thromboembolism in Lymphoma Patients: A Meta-Analysis

Cuiting Jiang, Jing Lv, Tingting Liu, Yao Liu

Blood (2023) 142 (Supplement 1): 1278.

https://doi.org/10.1182/blood-2023-182671

Published: 2023

Journal Articles

Clinical Study on the Efficacy and Safety of Peg Rhg CSF for Autologous Hematopoietic Stem Cell Mobilization in Lymphoma and Multiple Myeloma：a Randomized Controlled, Multicenter Clinical Study

Blood (2023) 142 (Supplement 1): 2222.

https://doi.org/10.1182/blood-2023-182517

Published: 2023

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Combined with High-Dose Chemotherapy As First-Line Treatment for HIV-Associated Lymphoma: A Retrospective Analysis

Bingling Guo, Renzhi Hu, Xiping Liang, Zailin Yang, Tao Yang, Chaoyu Wang, Chongling Hu, Wenjun Zhang, Chunyan Xiao, Jun Liu, Dehong Huang, Tingting Liu, Yingyu Nan, Jieping Li, Yao Liu

Blood (2023) 142 (Supplement 1): 6295.

https://doi.org/10.1182/blood-2023-181393

Published: 2023

Journal Articles

Application of Comprehensive Nursing Program Based on Evidence-Based Concept in Patients with HIV-Related Lymphoma

Jing Lv, Cuiting Jiang, Xia Wang, Yuhong Deng, Qin Luo, Tingting Liu, Yao Liu

Blood (2023) 142 (Supplement 1): 7265.

https://doi.org/10.1182/blood-2023-182681

Published: 2023

Journal Articles

Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial

Blood (2022) 140 (Supplement 1): 9540–9541.

https://doi.org/10.1182/blood-2022-168308

Published: 2022

Journal Articles

Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma

Zhuoxiao Cao, Cuiqing Yang, Yifang Wang, Chao Wang, Qingyang Wang, Gang Ye, Tingting Liu, Qin Wang, Huanyu Wang, Yanxue Gong, Biye Wang, Fuwei Jiang

Blood (2022) 140 (Supplement 1): 7378.

https://doi.org/10.1182/blood-2022-159289

Published: 2022

Journal Articles

Targeting Sumoylation with Subasumstat (TAK-981), a Selective Inhibitor of SUMO-Activating Enzyme (SAE), Induces Mitochondrial Dysfunction in Preclinical Models of Non-Hodgkin Lymphoma (NHL)

Tingting Liu, Vi Lam, Elana Thieme, Olga Danilova, Nur Bruss, Lapo Alinari, Jeffrey W. Tyner, Stephen E. Kurtz, Zheng Xia, Alexey V Danilov

Blood (2022) 140 (Supplement 1): 6016–6017.

https://doi.org/10.1182/blood-2022-159691

Published: 2022

Journal Articles

Disrupting MGA-MYC Driven Metabolic Reprogramming in Richter's Syndrome Pre-Clinical Models Via Novel Therapeutic Approaches

Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Hart, Joo Y. Song, Wing C Chan, Tanya Siddiqi, Alexey V Danilov, Steve T Rosen, Lili Wang

Blood (2022) 140 (Supplement 1): 9842–9843.

https://doi.org/10.1182/blood-2022-162664

Published: 2022

Journal Articles

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with HIV-Associated Aggressive B-Cell NHL in China

Chaoyu Wang, Jun Liu, Bingling Guo, Renzhi Hu, Tingting Liu, Jing Wu, Yao Ding, Chongling Hu, Shunsi Liang, Chunyan Xiao, Dehong Huang, Tao Yang, Wenjun Zhang, Zailin Yang, Jieping Li, Yingyu Nan, Qiying Li, Ying Xiang, Yao Liu

Blood (2022) 140 (Supplement 1): 11925.

https://doi.org/10.1182/blood-2022-155674

Published: 2022

Journal Articles

MGA deletion Leads to Richter's Transformation Via NME1

Prajish Iyer, Bo Zhang, Tingting Liu, Meiling Jin, Kevyn Hart, Joo Y. Song, John Chan, Raju Pillai, Tanya Siddiqi, Alexey V. Danilov, Steven T. Rosen, Lili Wang

Blood (2021) 138 (Supplement 1): 252.

https://doi.org/10.1182/blood-2021-148953

Published: 2021

Journal Articles

Transcriptional Reprogramming of Super-Enhancer Associated Oncogenes Following Inhibition of Cyclin-Dependent Kinase-9 (CDK9) in Aggressive Non-Hodgkin Lymphoma (NHL)

Elana Thieme, Duanchen Sun, Geeta G Sharma, Nur Bruss, Tingting Liu, Daniel J Coleman, Zheng Xia, Alexey V. Danilov

Blood (2021) 138 (Supplement 1): 3493.

https://doi.org/10.1182/blood-2021-149725

Published: 2021

Journal Articles

Nedd8-Activating Enzyme Inhibition Enhances Anti-Tumor Immunity and PD1 Blockade in In Vivo lymphoma Models

Xiaoguang Wang, Vi Lam, Dan Vuong, Tingting Liu, Olga Danilova, Tanya Siddiqi, Allison J Berger, Lili Wang, Alexey V. Danilov

Blood (2021) 138 (Supplement 1): 2414.

https://doi.org/10.1182/blood-2021-146349

Published: 2021

Journal Articles

Pharmacologic Inhibition of SUMO-Activating Enzyme Potentiates Interferon Response and T Cell-Mediated Anti-Tumor Immunity in Chronic Lymphocytic Leukemia (CLL) and Lymphoma Models

Vi Lam, Xiaoguang Wang, Scott R Best, Nur Bruss, Tingting Liu, Olga Danilova, Tanya Siddiqi, Nathan Pennock, Alexey V. Danilov

Blood (2021) 138 (Supplement 1): 3719.

https://doi.org/10.1182/blood-2021-146347

Published: 2021

Journal Articles

Pharmacologic Inhibition of B Cell-Receptor-Associated Kinases with CG-806 Induces Apoptosis and Metabolic Reprogramming in Aggressive Non-Hodgkin Lymphoma (NHL) Models

Elana Thieme, Vi Lam, Nur Bruss, BS, Fei Xu, Stephen E Kurtz, PhD, Jeffrey W. Tyner, PhD, Alexey Danilov, MD, Tingting Liu

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-134957

Published: 2020

Journal Articles

Pharmacologic Targeting MCL1 with AZD5991 Induces Apoptosis and Mitochondrial Dysfunction in Non-Hodgkin Lymphoma (NHL) Cells

Tingting Liu, Fei Xu, Elana Thieme, Vi Lam, Guang Fan, MD PhD, Liana Nikolaenko, MD, Stephen E Kurtz, PhD, Jeffrey W. Tyner, PhD, Olga Danilova, Alexey Danilov, MD

Blood (2020) 136 (Supplement 1): 33.

https://doi.org/10.1182/blood-2020-134951

Published: 2020

Journal Articles

Neddylation Pathway Regulates Treg Differentiation and T Cell Function in Chronic Lymphocytic Leukemia (CLL) Ex Vivo and Murine In Vivo Studies

Scott R Best, BS, Vi Lam, Nur Bruss, BS, Taylor Hashiguchi Rowland, BS, Adam S. Kittai, MD, Tingting Liu, Allison J Berger, PhD, Alexey Danilov, MD PhD

Blood (2019) 134 (Supplement_1): 4313.

https://doi.org/10.1182/blood-2019-123600

Published: 2019

Journal Articles

Pharmacologic Inhibition of SUMO-Activating Enzyme (SAE) with TAK-981 Augments Interferon Signaling and Regulates T Cell Differentiation in Ex Vivo studies of Chronic Lymphocytic Leukemia (CLL)

Vi Lam, Scott R Best, BS, Nur Bruss, BS, Tingting Liu, Taylor Hashiguchi Rowland, BS, Dennis Huszar, PhD, Alexey Danilov, MD PhD

Blood (2019) 134 (Supplement_1): 1760.

https://doi.org/10.1182/blood-2019-127539

Published: 2019

Journal Articles

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/RarÎ± Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Dijiong Wu, Keding Shao, MD, Qihao Zhou, MD, Jie Sun, Ziqi Wang, Fei Yan, Tingting Liu, Xiangping Wu, Baodong Ye, He Huang, MD PhD, Yuhong Zhou

Blood (2018) 132 (Supplement 1): 2646.

https://doi.org/10.1182/blood-2018-99-115699

Published: 2018

Journal Articles

Characterization of Causal Variants at the GATA3 Loci Associated with Susceptibility to Ph-like Acute Lymphoblastic Leukemia

Hui Zhang, PhD MD, Hongbo Yang, PhD, Tingting Liu, PhD, Maoxiang Qian, PhD, Wenjian Yang, PhD, Kathryn G. Roberts, PhD, Virginia Perez-Andreu, MD PhD, Heng Xu, PhD, Julie M. Gastier-Foster, PhD, Colton Smith, PhD, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD, Stephen P. Hunger, MD, Charles G. Mullighan, MBBS, MD, Mignon L. Loh, MD, Feng Yue, PhD, Jun J. Yang, PhD

Blood (2017) 130 (Supplement 1): 475.

https://doi.org/10.1182/blood.V130.Suppl_1.475.475

Published: 2017

NARROW

Zanubrutinib Combined with R-CHOP As the First-Line Treatment for Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Prospective Phase II Trial in China

Risk Factors of Venous Thromboembolism in Lymphoma Patients: A Meta-Analysis

Clinical Study on the Efficacy and Safety of Peg Rhg CSF for Autologous Hematopoietic Stem Cell Mobilization in Lymphoma and Multiple Myeloma：a Randomized Controlled, Multicenter Clinical Study

Autologous Hematopoietic Stem Cell Transplantation Combined with High-Dose Chemotherapy As First-Line Treatment for HIV-Associated Lymphoma: A Retrospective Analysis

Application of Comprehensive Nursing Program Based on Evidence-Based Concept in Patients with HIV-Related Lymphoma

Efficacy and Safety of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Single-Arm, Prospective Phase II Trial

Allogeneic CAR-NK Cell Therapy Targeting Both BCMA and GPRC5D for the Treatment of Multiple Myeloma

Targeting Sumoylation with Subasumstat (TAK-981), a Selective Inhibitor of SUMO-Activating Enzyme (SAE), Induces Mitochondrial Dysfunction in Preclinical Models of Non-Hodgkin Lymphoma (NHL)

Disrupting MGA-MYC Driven Metabolic Reprogramming in Richter's Syndrome Pre-Clinical Models Via Novel Therapeutic Approaches

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with HIV-Associated Aggressive B-Cell NHL in China

MGA deletion Leads to Richter's Transformation Via NME1

Transcriptional Reprogramming of Super-Enhancer Associated Oncogenes Following Inhibition of Cyclin-Dependent Kinase-9 (CDK9) in Aggressive Non-Hodgkin Lymphoma (NHL)

Nedd8-Activating Enzyme Inhibition Enhances Anti-Tumor Immunity and PD1 Blockade in In Vivo lymphoma Models

Pharmacologic Inhibition of SUMO-Activating Enzyme Potentiates Interferon Response and T Cell-Mediated Anti-Tumor Immunity in Chronic Lymphocytic Leukemia (CLL) and Lymphoma Models

Pharmacologic Inhibition of B Cell-Receptor-Associated Kinases with CG-806 Induces Apoptosis and Metabolic Reprogramming in Aggressive Non-Hodgkin Lymphoma (NHL) Models

Pharmacologic Targeting MCL1 with AZD5991 Induces Apoptosis and Mitochondrial Dysfunction in Non-Hodgkin Lymphoma (NHL) Cells

Neddylation Pathway Regulates Treg Differentiation and T Cell Function in Chronic Lymphocytic Leukemia (CLL) Ex Vivo and Murine In Vivo Studies

Pharmacologic Inhibition of SUMO-Activating Enzyme (SAE) with TAK-981 Augments Interferon Signaling and Regulates T Cell Differentiation in Ex Vivo studies of Chronic Lymphocytic Leukemia (CLL)

Autophagy and Ubiquitin-Mediated Proteolytic Degradation of PML/RarÎ± Fusion Protein in Matrine-Induced Differentiation Sensitivity Recovery of ATRA-Resistant APL (NB4-LR1) Cells: In Vitro and In Vivo studies

Characterization of Causal Variants at the GATA3 Loci Associated with Susceptibility to Ph-like Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only